Lassen A T, Hallas J, Schaffalitzky de Muckadell O B
Department of Medical Gastroenterology, Odense University Hospital, 5000 Odense C, Denmark.
Gut. 2004 Dec;53(12):1758-63. doi: 10.1136/gut.2004.043570.
Dyspepsia is a chronic disease with significant impact on the use of health care resources. A management strategy based on Helicobacter pylori testing has been recommended but the long term effect is unknown.
To investigate the long term effect of a test and treat strategy compared with prompt endoscopy for management of dyspeptic patients in primary care.
A total of 500 patients presenting in primary care with dyspepsia were randomised to management by H pylori testing plus eradication therapy (n = 250) or by endoscopy (n = 250). Results of 12 month follow up have previously been presented.
Symptoms, quality of life, and patient satisfaction were recorded during a three month period, a median 6.7 years after randomisation (range 6.1-7.3 years). Number of endoscopies, antisecretory medication, H pylori treatments, and hospital visits were recorded from health care databases for the entire follow up period.
Median age was 45 years; 28% were H pylori infected. Use of resources was registered in all 500 patients (3084 person years) of whom 312 completed diaries. We found no difference in symptoms between the two groups. Median proportion of days without symptoms was 0.52 (interquartile range 0.10-0.88) in the test and eradicate group versus 0.64 (0.14-0.90) in the prompt endoscopy group (p = 0.27) (mean difference 0.05 (95% confidence interval (CI) -0.03 to 0.14)). Compared with the prompt endoscopy group, the test and eradicate group underwent fewer endoscopies (mean difference 0.62 endoscopies/person (95% CI 0.38-0.86)) and used less antisecretory medication (mean difference 102 defined daily doses/person (95% CI -1 to 205)).
On a long term basis, a H pylori test and eradicate strategy is as efficient as prompt endoscopy for management of dyspeptic patients in primary care and reduces the use of endoscopy and antisecretory medication.
消化不良是一种对医疗资源使用有重大影响的慢性病。已推荐基于幽门螺杆菌检测的管理策略,但长期效果未知。
调查在基层医疗中,检测和治疗策略与立即进行内镜检查相比,对消化不良患者管理的长期效果。
共有500名在基层医疗中出现消化不良症状的患者被随机分为两组,一组接受幽门螺杆菌检测加根除治疗(n = 250),另一组接受内镜检查(n = 250)。之前已公布12个月随访结果。
在随机分组后中位数6.7年(范围6.1 - 7.3年)的三个月期间,记录症状、生活质量和患者满意度。从医疗保健数据库记录整个随访期间的内镜检查次数、抗分泌药物使用情况、幽门螺杆菌治疗次数和住院就诊次数。
中位年龄为45岁;28%感染幽门螺杆菌。在所有500名患者(3084人年)中记录了资源使用情况,其中312人完成了日记记录。我们发现两组症状无差异。检测和根除组无症状天数的中位数比例为0.52(四分位间距0.10 - 0.88),立即内镜检查组为0.64(0.14 - 0.90)(p = 0.27)(平均差异0.05(95%置信区间(CI)-0.03至0.14))。与立即内镜检查组相比,检测和根除组接受的内镜检查较少(平均差异0.62次内镜检查/人(95%CI 0.38 - 0.86)),使用的抗分泌药物较少(平均差异102限定日剂量/人(95%CI -1至205))。
长期来看,幽门螺杆菌检测和根除策略在基层医疗中对消化不良患者的管理与立即进行内镜检查一样有效,并减少了内镜检查和抗分泌药物的使用。